MARKET VECTORS ETF TR - BIOTECH ETF (BBH)

CUSIP: 57060U183

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / BIOTECH ETF
Total 13F shares
2,535,165
Share change
+102,223
Total reported value
$290,101,302
Put/Call ratio
205%
Price per share
$114.31
Number of holders
80
Value change
+$10,469,440
Number of buys
31
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 57060U183?
CUSIP 57060U183 identifies BBH - MARKET VECTORS ETF TR - BIOTECH ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - BIOTECH ETF (BBH) as of Q3 2015

As of 30 Sep 2015, MARKET VECTORS ETF TR - BIOTECH ETF (BBH) was held by 80 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,535,165 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, CREDIT SUISSE AG/, UBS Group AG, MORGAN STANLEY, CITIGROUP INC, MURPHY CAPITAL MANAGEMENT INC, VALLEY FORGE ASSET MANAGEMENT, LLC, BB&T CORP, LPL Financial LLC, and Tower Research Capital LLC (TRC). This page lists 80 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.